Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 5.6B | 5.3B | 4.8B | 4.7B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 1.8B | 1.6B | 1.6B | 1.6B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 2.5B | 2.3B | 1.8B | 1.7B |
| Tax provision | 546M | 465M | 434M | 415M |
| Net income | 1.9B | 1.8B | 1.4B | 1.3B |
| Basic EPS | 1.0 | 0.9 | 0.7 | 0.7 |
| Diluted EPS | 1.0 | 0.9 | 0.7 | 0.7 |
| Basic average shares | 1.8B | 1.8B | 1.8B | 1.8B |
| Diluted average shares | 1.8B | 1.8B | 1.8B | 1.8B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 1.9B | 1.8B | 1.4B | 1.3B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |